fbpx

Beyond the Pitch

Nationwide Children’s Hospital Dedicated to Life-saving Gene Therapies

It is excellent to see a local leader featured in this inspiring Xconomy story about Nationwide Children’s Hospital’s brave commitment to saving children’s lives by researching, testing, and spinning out promising gene therapies.

This quote from Xconomy says it all:

“Thanks to ambitious officials, a risk-taking administration, and a tight connection between its labs and its hospital practice, Nationwide has become a gene therapy leader.” — Ben Fidler, Xconomy

At Rev1, we see first-hand the incredible dedication of the scientists and entrepreneurs from the Columbus region who are mentioned in the article.

Rev1 manages the NCH Fund I, which focuses on Nationwide Children’s Hospital spinouts as well as the Catalyst Fund, which includes investments from The Ohio State University, Nationwide Children’s Hospital, Ohio Third Frontier, and Rev1 Ventures. Two of the companies mentioned in this article, Celenex (Acquired by Amicus Therapeutics) and Myonexus Therapeutics (acquired by Sarepta).

We celebrate their persistence and groundbreaking discoveries.

Read the entire Xconomy article.

  • Get startup tips and resources delivered directly to your inbox.

  • Resources

    Getting Started
    Tips for turning a concept into a company

    Getting Customers
    From honing your pitch to getting your first customer

    Success Stories
    Entrepreneur Success

    Getting Funding
    How and where to get the cash you need to grow

    The Hard Stuff
    How to navigate hiring, taxes, legal and more

    The Network Effect
    Making the right connections at the right time

    #Startup Buzz
    The news and trends that matter to you

    Rev1 News & Events
    The latest buzz and networking opportunities